Louisiana-pacific Corp

Insider Buying Week 11-14-25 the Busiest Week of the Year

by

This was the busiest week we’ve seen this year for insider buying. You hear a lot about what a great year the market is having but the buyers of these stocks would vehemently disagree.  There are 61 buys we are monitoring and 55 of them are in negative territory for the year. Insiders are the consummate value buyer, preferring to invest in their own company’s stock when it is on sale.  Sometimes that might be taking a bullet for the team or trying to paint the tape.  But when they buy in size with their own money, it’s likely they … Read more

Insider Buying week 11-19-21- Insiders are Stepping up

by

Curious how well insiders are doing with their buys? Click on this link or image above to scroll the significant buys of the last year. This report is going to be delayed due to a funeral I had to attend for my dear first cousin’s, husband, who passed away at 75years of age. It brought me back to Savannah, my hometown, on the marsh and waterways of Skidaway Island. I will get to the opinion pieces as I write the Insiders Report for myself. It’s my way of processing insider buying.  And there was a lot of it, this time … Read more

Insider Buying picks up Last Week- 57 Buys in 41 Different Companies

by

For trade, details click on this link to the trades.  Wow- Insiders are coming back with a vengeance. The S&P was up 0.71% for the week ending the week with new highs on the S&P 500, the Dow, and the QQQ indices. Insiders returned to the playing field with an average return of 2.67% for the week, easily beating the market.  In this blog post, we analyze, 57 insider buys in about 41 different companies. Now you know what I didn’t do with my weekend.  We highlight the insider purchases that stood out, mostly over $200k and personal money, not … Read more

Insider Buying Picks Up Dramatically Week 8-06-21

by

For trade, details click on this link to the trades.  Name Sachs Bruce I Position: Director Shares Bought: 15,000 Average Price Paid: $197.91, Cost: $2,968,650 Company: Vertex Pharmaceuticals Inc. (VRTX) Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) – a rare, life-threatening genetic disease – and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational small molecule medicines in other serious diseases where it has … Read more